Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.050
0.00 (0.00%)
At close: Jul 16, 2026
HRGN Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.89 | 0.7 | 0.43 | 0.1 | - | - | |
Revenue Growth (YoY) | 111.72% | 63.72% | 317.48% | - | - | - |
Cost of Revenue | 0.82 | 0.65 | 0.27 | 0.02 | - | - |
Gross Profit | 0.07 | 0.06 | 0.16 | 0.08 | - | - |
Selling, General & Admin | 4.35 | 4.36 | 5.14 | 6.08 | 4.4 | 7.12 |
Research & Development | 2.57 | 2.61 | 2.24 | 2.99 | 1.67 | 1.52 |
Operating Expenses | 6.92 | 6.97 | 7.39 | 9.07 | 6.07 | 8.64 |
Operating Income | -6.85 | -6.92 | -7.23 | -8.99 | -6.07 | -8.64 |
Interest Expense | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 | - |
Interest & Investment Income | 0.03 | 0.04 | 0.03 | 0.06 | - | - |
Other Non Operating Income (Expenses) | 0.02 | 0.02 | - | -0.01 | 0 | 0.25 |
EBT Excluding Unusual Items | -6.81 | -6.87 | -7.23 | -8.95 | -6.07 | -8.39 |
Other Unusual Items | - | - | -0.5 | - | - | 0.41 |
Pretax Income | -6.81 | -6.87 | -7.73 | -8.95 | -6.07 | -7.98 |
Net Income | -6.81 | -6.87 | -7.73 | -8.95 | -6.07 | -7.98 |
Preferred Dividends & Other Adjustments | - | - | - | 0.08 | 0.18 | - |
Net Income to Common | -6.81 | -6.87 | -7.73 | -9.02 | -6.25 | -7.98 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 17 | 17 | 15 | 13 | 11 | 10 |
Shares Outstanding (Diluted) | 17 | 17 | 15 | 13 | 11 | 10 |
Shares Change (YoY) | 10.80% | 11.68% | 9.91% | 18.56% | 12.79% | 14.43% |
EPS (Basic) | -0.40 | -0.42 | -0.52 | -0.67 | -0.55 | -0.79 |
EPS (Diluted) | -0.40 | -0.42 | -0.52 | -0.67 | -0.55 | -0.79 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -4.01 | -3.83 | -4.85 | -6.95 | -5.11 | -2.63 |
Free Cash Flow Per Share | -0.24 | -0.23 | -0.33 | -0.52 | -0.45 | -0.26 |
Gross Margin | 7.46% | 8.24% | 37.21% | 76.70% | - | - |
Operating Margin | -774.12% | -982.24% | -1680.46% | -8728.15% | - | - |
Profit Margin | -769.61% | -975.71% | -1798.14% | -8759.22% | - | - |
Free Cash Flow Margin | -452.77% | -543.75% | -1128.37% | -6747.57% | - | - |
EBITDA | -6.85 | -6.91 | -7.21 | -8.96 | -6.01 | -8.53 |
D&A For EBITDA | 0 | 0.01 | 0.01 | 0.04 | 0.05 | 0.11 |
EBIT | -6.85 | -6.92 | -7.23 | -8.99 | -6.07 | -8.64 |